[1]
2014. Evaluation of the effectiveness of platinum-based chemotherapy in ovarian cancer patients carriers of mutations in BRCA1/2. Voprosy onkologii. 60, 3 (Dec. 2014), 339–342. DOI:https://doi.org/10.37469/0507-3758-2014-60-3-339-342.